Literature DB >> 819616

Purification and characterization of leucocidin from Pseudomonas aeruginosa.

W Scharmann.   

Abstract

Leucocidin from Pseudomonas aeruginosa strain 158 was released from bacteria by autolysis and purified 19-fold by ammonium sulphate precipitation (20% saturation) and combined 'tandem' gel filtration on Sephadex G-100 superfine and Bio Gel P-100. The product gave a single band (mol. wt. 27000) after poly-acrylamide gel electrophoresis with sodium dodecyl sulphate (SDS). However, it was separated into two active peaks (pI 5-0 and 5-2) by isoelectric focusing, and into five bands by disc electrophoresis without SDS. All bands contained leucocidic activity of about the same specific activity and retained their homogeneity. The purified toxin was thermolabile and was inactivated by pronase, but not by several other proteases. The ultraviolet light absorbancy was typical of proteins. Antibodies directed against leucocidin were detected by passive haemagglutination and by toxin-neutralization. These antibodies inhibited the cytotoxic action of leucocidin bound to granulocytes. The toxin damaged all tested leucocytes (granulocytes of various animal species and lymphocytes of humans) and a number of tissue cultures, but was ineffective against erythrocytes, thrombocytes and isolated granules from polymorphonuclear leucocytes. The intravenous lethal dose for mice was about 1 mug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819616     DOI: 10.1099/00221287-93-2-292

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  17 in total

1.  Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism.

Authors:  C C Tsai; W P McArthur; P C Baehni; B F Hammond; N S Taichman
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

3.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Interaction of Pseudomonas aeruginosa cytotoxin with plasma membranes from Ehrlich ascites tumor cells.

Authors:  F Lutz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

5.  In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.

Authors:  R S Berk; D Brown; I Coutinho; D Meyers
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Mode of cytotoxic action of pseudomonal leukocidin on phosphatidylinositol metabolism and activation of lysosomal enzyme in rabbit leukocytes.

Authors:  T Hirayama; I Kato
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  Binding of pseudomonal leukocidin to rabbit polymorphonuclear leukocytes.

Authors:  T Hirayama; M Noda; F Matsuda; M Nagamori; I Kato
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

8.  Production of leukocidin by clinical isolates of Pseudomonas aeruginosa and antileukocidin antibody from sera of patients with diffuse panbronchiolitis.

Authors:  J Y Homma; M Matsuura; M Shibata; Y Kazuyama; M Yamamoto; Y Kubota; T Hirayama; I Kato
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

9.  Effect of Pseudomonas aeruginosa cytotoxin on thymidine incorporation by murine splenocytes.

Authors:  T G Obrig; A L Baltch; T P Moran; S P Mudzinski; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Rat polyvinyl sponge model for the study of infections: host factors and microbial proliferation.

Authors:  H D Isenberg; S L Wiener; G A Isenberg; J Sampson-Scherer; M Urivetzky; J I Berkman
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.